On 28 July, Capnia, Inc. (NASDAQ:CAPN) announced it has entered into a common stock purchase agreement with Aspire Capital Fund, LLC. Capnia, Inc. (NASDAQ:CAPN) belongs to Healthcare sector. Its weekly performance is -52.87%. On last trading day company shares ended up $1.15. Capnia, Inc. (NASDAQ:CAPN) distance from 50-day simple moving average (SMA50) is -64.79%.
Plains GP Holdings LP (NYSE:PAGP) on Tuesday reported second-quarter earnings of $30 million. On a per-share basis, the Houston-based company said it had profit of 14 cents. The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 17 cents per share. The oil and gas holding company posted revenue of $6.66 billion in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $5.9 billion. Plains GP Holdings, L.P. (NYSE:PAGP) shares fell -23.17% in last trading session and ended the day at $18.73. PAGP Gross Margin is 10.20% and its return on assets is 0.40%. Plains GP Holdings, L.P. (NYSE:PAGP) quarterly performance is -32.30%.
General Electric Co (NYSE:GE) has received its first French order for the low-wind 2.75 MW-120 turbine. GE will supply five turbines to a 13.75-MW wind farm project near Crosey Le Grand, in the Franche Comte region of France, the company said in a press release on Wednesday. General Electric Company (NYSE:GE) shares moved up 0.77% in last trading session and ended the day at $26.10. GE Gross Margin is 37.50% and its return on assets is -1.00%. General Electric Company (NYSE:GE) quarterly performance is -1.82%.
Morgan Stanley reissued their overweight rating on shares of Spirit Airlines Inc. (NASDAQ:SAVE) in a report issued on Tuesday. Spirit Airlines, Inc. (NASDAQ:SAVE) ended the last trading day at $61.08. Company weekly volatility is calculated as 2.71% and price to cash ratio as 5.79. Spirit Airlines, Inc. (NASDAQ:SAVE) showed a weekly performance of 0.91%.
Genomic Health, Inc. (NASDAQ:GHDX) today reported financial results and business progress for the quarter ended June 30, 2015. Revenue was $70.6 million in the second quarter of 2015 compared with $70.5 million for the second quarter of 2014. International revenue was $9.9 million in the second quarter of 2015, down from $11.9 million in the second quarter of 2014, and represented 14 percent of revenue in the quarter. Genomic Health Inc. (NASDAQ:GHDX) belongs to Healthcare sector. Its net profit margin is -9.60% and weekly performance is -4.70%. On last trading day company shares ended up $25.37. Genomic Health Inc. (NASDAQ:GHDX) distance from 50-day simple moving average (SMA50) is -5.98%.